Back

Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Heart failure outcome Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

9 More presentations in this session

Presentation thumbnail
Doctor X. Chen (Chengdu, CN)
Abstract
Presentation thumbnail
Associate Professor A. Kosztin (Budapest, HU)
Abstract
Presentation thumbnail
Mr Y. Iwasaki (Tokyo, JP)
Abstract
Presentation thumbnail
Doctor W. Chen (Guangzhou, CN)
Abstract
Presentation thumbnail
Doctor H. Arfsten (Vienna, AT)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Heart failure outcome

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Regional differences in initiation of sacubitril/valsartan in HFrEF patients after hospitalisation for acute decompensated heart failure: Post-hoc analysis of the TRANSITION study
29 June 2021
thumbnail
Congress Presentation
Predictors of rehospitalization due to congestive heart failure
20 May 2023
thumbnail
Congress Presentation
Implementation of a transitional care programme for heart failure and its impact on 30-day readmissions and emergency department visits
31 August 2025
thumbnail
Congress Presentation
Effects of dapagliflozin on hospitalizations for heart failure according to severity of inpatient treatment course: the DELIVER Trial
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources